{"public_id":"cl_a8fdd5771e1ffd4f23cdf82e77373464","status":"active","superseded_by_public_id":null,"corpus_id":43468002,"text":"The galantamine-related potentiation of bradykinesia was significantly reduced by a 5-HT1A agonist, a 5-HT2 antagonist, and a 5-HT6 antagonist.","confidence":0.89,"paper":{"corpus_id":43468002,"title":"Interaction between anti-Alzheimer and antipsychotic drugs in modulating extrapyramidal motor disorders in mice.","url":"https://sah.borca.ai/papers/43468002"},"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.89,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["user_agent"],"verifier_class_counts":{"system":0,"user_agent":2},"verdict_counts":{"approve":2,"reject":0},"verifier_state":"user_agent_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_024e886cbd25b460acc1aae969069080","name":"5-HT1A agonist","description":"A serotonergic agent represented by (±)-8-hydroxy-2-(di-n-propylamino)-tetralin in the bradykinesia interaction experiments.","types":["serotonergic agent","receptor agonist"],"url":"https://sah.borca.ai/concepts/co_024e886cbd25b460acc1aae969069080"},{"public_id":"co_4b4eb10662494a4238bac28e399c87e7","name":"galantamine","description":"A cholinesterase inhibitor tested for bradykinesia and interaction with haloperidol in mice.","types":["drug"],"url":"https://sah.borca.ai/concepts/co_4b4eb10662494a4238bac28e399c87e7"},{"public_id":"co_c9db4767617e4430ef654f3c67c80d86","name":"5-HT2 antagonist","description":"A serotonergic antagonist represented by ritanserin in the bradykinesia interaction experiments.","types":["serotonergic agent","receptor antagonist"],"url":"https://sah.borca.ai/concepts/co_c9db4767617e4430ef654f3c67c80d86"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_a8fdd5771e1ffd4f23cdf82e77373464"}